Table 1 Biomarkers of participants in ATAAD
No 30-day death | 30-day death | P-value | No Death | Death | P-value | |
|---|---|---|---|---|---|---|
N | 143 | 17 | 128 | 32 | ||
TAZ, ng/ml | 14.3 ± 3.0 | 14.0 ± 2.5 | 0.656 | 14.5 ± 3.0 | 13.6 ± 2.4 | 0.151 |
YAP 1, ng/ml | 11.3 ± 2.6 | 11.3 ± 2.7 | 0.915 | 11.2 ± 2.6 | 11.9 ± 2.8 | 0.140 |
YAP 2, ng/ml | 10.8 ± 2.6 | 10.8 ± 3.0 | 0.981 | 10.7 ± 2.5 | 11.1 ± 3.1 | 0.384 |
MST 1, pg/ml | 1152.4 ± 255.7 | 1386.6 ± 139.3 | < 0.001* | 1157.0 ± 252.5 | 1258.3 ± 258.5 | 0.045* |
MST 2, pg/ml | 1108.2 ± 242.0 | 1145.3 ± 245.1 | 0.551 | 1115.6 ± 243.1 | 1098.2 ± 240.1 | 0.718 |
LATS 1, ng/ml | 9.1 ± 1.9 | 8.2 ± 1.8 | 0.070 | 9.1 ± 1.9 | 8.6 ± 1.8 | 0.159 |
LATS 2, ng/ml | 8.6 ± 1.7 | 8.8 ± 1.9 | 0.677 | 8.7 ± 1.7 | 8.5 ± 1.7 | 0.440 |